Startup entity
Every one of those 1 sits in a single category, funding. Korro Bio is most often covered alongside OPERA Platform, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.7 in the same window.
Last mentioned: Mar 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Korro Bio is most often covered alongside OPERA Platform, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.7 in the same window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. Korro Bio appears in 1 tracked Startup story from March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 43 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Korro Bio. Shared-story counts are live from our verified record — not editorial picks.
$85M Private Placement
Company announces oversubscribed funding to accelerate clinical trials.
Platform Validation
Preclinical data for lead AATD program shows high editing efficiency.
Merger Completion
Korro Bio becomes a public entity via merger with Freeline Therapeutics.
Korro Bio has announced an oversubscribed $85 million private placement, signaling strong investor confidence in its proprietary RNA editing platform. This capital injection is expected to extend the company's cash runway and accelerate the clinical development of its lead programs targeting genetic diseases.
Korro Bio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
